Table 2.
Clinical, biological, therapeutic and evolution features of previously reported cases of TCRBCL associated HLH
| Case | Sex | Age | Clinical features | Laboratory findings | Pathology | EBV | Treatment | Outcome |
|---|---|---|---|---|---|---|---|---|
| Mitterrer et al. [9] | Female | 30 | B symptoms, splenomegaly | Moderate pancytopenia, high LDH | Spleen: hemophagocytosis Hepatic nodules: TCRBCL | Reactivated EBV infection serological profile | MOPP-ABV then high dose methotrexate, vincristine and etoposide followed by AHSCT | Sustained CR for 2 years |
| Devitt et al. [12] | Male | 30 | Fever, jaundice, B symptoms, splenomegaly, repiratory failure | Hyperferritinemia Pancytopenia Hyperbilirubinemia Elevated liver enzymes High LDH |
Bone marrow: Hemophagocytosis and lymphomatous infiltration | Negative (in situ hybridization) | HLH 2004, R-EPOCH | CR followed by AHSCT |
| Aljitawi et Boone [13] | Male | 34 | Relapse of previously treated TCRBCL Fever, jaundice, hepatosplenomegaly, ascites |
Hyperferritinemia Pancytopenia Hyperbilirubinemia High soluble IL2-R |
Bone marrow: Hemphagocytosis, relapsed TCRBCL | NA | Salvage therapy (NA) | Relapse after months and death |
| Jiang et al. [14] | Male | 20 | Jaundice Fatigue Abdominal disconfort Fever |
Acute hepatitis Pancytopenia Hyperferritinemia High soluble IL2-R |
Bone marrow and lymph node: TCRBCL | NA | R-CHOP | CR |
| Our case | Male | 52 | B symptoms, splenomegaly Lymph nodes |
Pancytopenia High LDH Hyperferritinemia |
Bone marrow: hemophagocytosis Lymph node: TCRBCL |
Negative (biopsy and peripheral blood PCR) | R-CHOP | Relapse after 10 months |
LDH lacticodeshydrogenase, R-EPOCH Rituximab, etoposide, prednisone, vincristine, cyclophosphamide and doxorubicine, CR complete remission, AHSCT autologous hematopoietic stem cell transplantation, TCRBCL T-cell rich B-cell lymphoma, MOPP-ABV mechlorethamine, vincristine, procarbazine, prednisone/doxorubicin, bleomycin, vincristine, PCR polymerase chain reaction